Antitumoral Action of Interferons and Interleukins in Combination with Radiotherapy. Part I: Immunologic Basis;Antitumorale Wirkung von Interferonen und Interleukinen in Kombination mit Strahlentherapie. Teil I: Immunologische Grundlagen

Strahlentherapie und Onkologie

Volumn 180, Issue 4, 2004, Pages 187-193

  Herskind, Carsten ^a,b,e   Fleckenstein, Katharina ^b   Lohr, Jens ^c   Li, Chuan Yuan ^d   Wenz, Frederik ^b   Lohr, Frank ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Klinikum   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Institut fur Klinische Radiologie   (Germany)

Author keywords

Biological response modifiers; Cytokines; Immune response; Interferon; Interleukin; Radiotherapy; Tumor associated antigens (TAA)

Indexed keywords

CYTOKINE; INTERFERON;

ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; CANCER RADIOTHERAPY; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; RADIOSENSITIZATION; REVIEW; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; CD8-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOTHERAPY; INTERFERONS; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES; TH2 CELLS; WHOLE-BODY IRRADIATION;

EID: 1842715065     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-9119-x     Document Type: Review

References (61)

1. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. Philadelphia: Saunders, 2000.
2. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
3. Arai H, Gordon D, Nabel EG, et al. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci U S A 1997;94:13862-7.
4. Belka C, Ottinger H, Kreuzfelder E, et al. Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol 1999;50:199-204.
5. Bendelac A, Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J Exp Med 2002;195:F19-23.
6. Brunda MJ, Luistro L, Hendrzak JA, et al. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J Immunother Emphasis Tumor Immunol 1995;17:71-7.
7. Brunda MJ, Luistro L, Warrier RR, et al. Antitumor and antimetastatic activity of interleukin 12 against mudne tumors. J Exp Med 1993;178:1223-30.
8. Cole S, Lewkowicz SJ, Townsend KM. Langerhans cell number and morphology in mouse footpad epidermis after X irradiation. Radiat Res 1984;100:594-606.
9. Dieckmann D, Plottner H, Berchtold S, et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-10.
10. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 1993;90:3539-43.
11. Fernandez NC, Levraud JP, Haddada H, et al. High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer. J Immunol 1999;162:609-17.
12. Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol 1996;170:101-10.
13. Gambotto A, Tuting T, McVey DL, et al. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Ther 1999;6:45-53.
14. Hareyama M, Imai K, Oouchi A, et al. The effect of radiation on the expression of intercellular adhesion molecule-1 of human adenocarcinoma cells. Int J Radiat Oncol Biol Phys 1998;40:691-6.
15. Hashimoto S, Shirato H, Hosokawa M, et al. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res 1999;151:717-24.
16. Herskind C, Bamberg M, Rodemann HP. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol 1998;174:Suppl 3:12-5.
17. Hughes AL, Yeager M. Molecular evolution of the vertebrate immune system. Bioessays 1997;19:777-86.
18. Kang SM, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997;3:738-43.
19. Kawakita M, Rao GS, Ritchey JK, et al. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J Natl Cancer Inst 1997;89:428-36.
20. Kawase Y, Naito S, Ito M, et al. The effect of ionizing radiation on epidermal Langerhans cells - a quantitative analysis of autopsy cases with radiation therapy. J Radiat Res (Tokyo) 1990;31:246-55.
21. Kurzawa H, Wysocka M, Aruga E, et al. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression. Cancer Res 1998;58:491-9.
22. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193:1295-302.
23. Lohr F, Herskind C, Lohr J, et al. Enhancement of the radiation response with interleukins/interferons. In: Milas L, Ang KK, Nieder E, eds. Biological modification of radiation response. Berlin-Heidelberg: Springer, 2003:205-26.
24. Lohr F, Hu K, Haroon Z, et al. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy. Mol Ther 2000;2:195-203.
25. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-8.
26. Meineke V, Gilbertz KP, Schilperoort K, et al. Ionizing radiation modulates cell surface integrin expression and adhesion of COLO-320 cells to collagen and fibronectin in vitro. Strahlenther Onkol 2002;178:709-14.
27. Melero I, Duarte M, Ruiz J, et at. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas. Gene Ther 1999;6:1779-84.
28. Morel A, Fernandez N, de La Coste A, et al. Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells. Cancer Immunol Immunother 1998;46:277-82.
29. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
30. Mushegian A, Medzhitov R. Evolutionary perspective on innate immune recognition. J Cell Biol 2001;155:705-10.
31. Nasu Y, Bangma CH, Hull GW, et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 1999;6:338-49.
32. Nishimura T, Kitamura H, Iwakabe K, et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000;12:987-94.
33. Nishioka Y, Hirao M, Robbins PD, et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res 1999;59:4035-41.
34. Ochsenbein AF, Sierro S, Odermatt B, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001;411:1058-64.
35. O'Connell, J, Bennett MW, O'Sullivan GC, et al. Fas counter-attack - the best form of tumor defense? Nat Med 1999;5:267-8.
36. Ogawa Y, Nishioka A, Hamada N, et al. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance. Clin Cancer Res 1997;3:2301-7.
37. Olkowski ZL. Functional response of human natural killer (NK) cells to ionizing radiation. Int J Radiat Oncol Biol Phys 1999;45:282-3.
38. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002;2:37-45.
39. Ostrand-Rosenberg S, Gunther V, Armstrong T, et al. Immunologic targets for the gene therapy of cancer. In: Lattime EC, ed. Gene therapy of cancer. London: Academic Press, 1999.
40. Oyama T, Ran S, Ishida T et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998;160:1224-32.
41. Pham-Nguyen KB, Yang W, Saxena R, et al. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int J Cancer 1999;81:813-9.
42. Pillai R, Balaram P, Nair BS, et al. Lymphocyte subset distribution after radiation therapy for cancer of the uterine cervix. Possible prognostic implications and correlation with disease course. Cancer 1991;67:2071-8.
43. Puisieux I, Odin L, Poujol D, et al. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. Hum Gene Ther 1998;9:2481-92.
44. Rodel F, Kamprad F, Sauer R, et al. Funktionelle und molekulare Aspekte der anti-inflammatorischen Wirkung niedrig dosierter Radiotherapie. Strahlenther Onkol 2002;178:1-9.
45. Roth C, Rochlitz C, Kourilsky P. Immune response against tumors. Adv Immunol 1994;57:281-351.
46. Rübe C, Finke C, van Valen F, et al. The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo. Strahlenther Onkol 1997;173:407-14.
47. Safwat A. The immunobiology of low-dose total-body irradiation: more questions than answers. Radiat Res 2000;153:599-604.
48. Santin A, Hermonat P, Ravaggi A, et al. The effects of irradiation on the expression of a tumor rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol 1998;73:699-704.
49. Sareneva T, Julkunen I, Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 2000;165:1933-8.
50. Sauer G, Deisster H, Kurzeder C, et al. New molecular targets of breast cancer therapy. Strahlenther Onkol 2002;178:123-33.
51. Seliger B, Harders C, Lohmann S, et al. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur J Immunol 1998;28:122-33.
52. Shibata T, Hosokawa M, Micallef M, et al. Enhancement of tumor antigen expression and inhibition of pulmonary metastasis of rat fibrosarcoma cells by local radiotherapy. Anticancer Res 1997;17:317-22.
53. Shresta S, Pham CT, Thomas DA, et al. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998;10:581-7.
54. Steinbrink K, Jonuleit H, Muller G, et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999;93:1634-42.
55. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001;193:1311-8.
56. Tisch M, Heimlich F, Daniel V, et al. Cellular immune defect caused by post-surgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 1998;119:412-7.
57. Van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 1999;190:355-66.
58. Velders MP, Schreiber H, Kast WM. Active immunization against cancer cells: impediments and advances. Semin Oncol 1998;25:697-706.
59. Wang C, Quevedo ME, Lannutti BJ, et al. In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model. J Invest Dermatol 1999;112:775-81.
60. Younes E, Haas GP, Dezso B, et al. Radiation-induced effects on murine kidney tumor cells: role in the interaction of local irradiation and immunotherapy. J Urol 1995;153:2029-33.
61. Yue FY, Geertsen R, Hemmi S, et al. IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol 1999;29:1762-73.